How is Increasing Cancer Prevalence Propelling Embolotherapy Market?
More than 840,000 new liver cancer cases were diagnosed around the world in 2018, according to the World Cancer Research Fund (WCRF). Similarly, other severe diseases, such as kidney cancer, aneurysms, and varicose veins, are also increasing in prevalence due to genetic predisposition, environmental factors, sedentary lifestyle, obesity, and alcohol abuse. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/embolotherapy-market/report-sample Several embolic agents and support devices are used for the procedure, of which embolic agents are used more. This is because of the advent of technologically advanced agents, such as radioactive Y-90 microspheres, which are utilized in the treatment of primary and secondary liver diseases, as well as calibrated microspheres, which are used during bland embolization. Moreover, the usage of embolic agents is increasing in interventional radiology procedures, which further helps augment the demand for these...